In the first major patent infringement lawsuit in the mRNA space, on February 28, 2022, Arbutus Biopharma Corporation (“Arbutus”) and
Continue Reading Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space
